Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announced the appointment of Lucie Larguier as Chief Financial Officer (CFO), effective immediately. Formerly VP, Corporate Communication and Investor Relations at Transgene, in her new role as CFO, Lucie Larguier will be responsible for all aspects of the Company’s financial…